Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Alexander Savio Ramos Guimaraes

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4601-9340; OpenAlex author ID A5044303900, A5111609588; NIH RePORTER profile ID 9495624. Sources: ClinicalTrials.gov.

Their work

Papers
11 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
3
Labs led
2
Collaborators
83
Papers, trials and grants by year

2013: 1 paper · 2014: 1 trial · 2015: 1 paper, 1 grant · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper, 1 grant · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper, 1 grant

Papers 11

  1. Surveillance for Pancreatic Cancer: Knowledge, Motivations, Barriers, and Preferences Among High-Risk Individuals and Underserved Populations. Co-author DOI 10.1177/10732748261468819↗
  2. Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Co-author DOI 10.1038/s43018-024-00881-3↗
  3. CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer. Co-author DOI 10.1080/14796694.2024.2395235↗
  4. Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of ab… Co-author DOI 10.1007/s00261-022-03693-0↗
  5. Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity. Co-author DOI 10.1093/narcan/zcad016↗
  6. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consor… Co-author DOI 10.2214/ajr.22.27859↗
  7. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-017-1433-8↗
  8. Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer. Co-author DOI 10.1038/s41598-017-08838-6↗
  9. Noninvasive Assessment of Losartan-Induced Increase in Functional Microvasculature and Drug Delivery in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.tranon.2016.07.004↗
  10. Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-1591↗
  11. FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Co-author DOI 10.1634/theoncologist.2012-0435↗

Trials 1

  1. DCE MRI in Patients With Pancreatic Cancer Principal investigator NCT02070705↗

Grants 3

  1. Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs U01CA278923↗
  2. Magnetic Resonance (MR) Fingerprinting for Quantification of Pancreatic Tumor Microvasculature R01DK117459↗
  3. Validation of MRI Microvascular Biomarkers in Pancreatic Cancer with Magnetic Nanoparticles K08EB012859↗

Closest collaborators

The 25 strongest of 83 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosalie C. Sears · 4 shared papers, 1 shared grant, 2023–2026 · strength 1.64
  2. Brett C. Sheppard · 3 shared papers, 1 shared grant, 2024–2026 · strength 1.47
  3. Gregory A. Coté · 1 shared paper, 1 shared grant, 2026 · strength 1.16
  4. Jonathan Robert Brody · 3 shared papers, 2023–2025 · strength 0.48
  5. Avinash R. Kambadakone · 3 shared papers, 2018–2023 · strength 0.33
  6. Terry K. Morgan · 2 shared papers, 2023–2025 · strength 0.33
  7. Gordon Brent Mills · 2 shared papers, 2024–2025 · strength 0.31
  8. Adel Kardosh · 2 shared papers, 2024–2025 · strength 0.31
  9. Charles D. Lopez · 2 shared papers, 2024–2025 · strength 0.31
  10. Emily Van Houweling · 1 shared paper, 2026 · strength 0.30
  11. Jackilen Shannon · 1 shared paper, 2026 · strength 0.30
  12. Lyndon Luk · 2 shared papers, 2022–2023 · strength 0.26
  13. Elizabeth M. Hecht · 2 shared papers, 2022–2023 · strength 0.26
  14. Ott Le · 2 shared papers, 2018–2023 · strength 0.20
  15. Eric Peter Tamm · 2 shared papers, 2018–2023 · strength 0.20
  16. Erik V. Soloff · 2 shared papers, 2018–2023 · strength 0.20
  17. Lorenzo Mannelli · 2 shared papers, 2018–2023 · strength 0.20
  18. Priya Bhosale · 2 shared papers, 2018–2023 · strength 0.20
  19. Atif Zaheer · 2 shared papers, 2018–2023 · strength 0.20
  20. Aditi Jain · 1 shared paper, 2023 · strength 0.17
  21. Jennifer M. Finan · 1 shared paper, 2023 · strength 0.17
  22. Yifei Guo · 1 shared paper, 2023 · strength 0.17
  23. Grace A. McCarthy · 1 shared paper, 2023 · strength 0.17
  24. Emek Demir · 1 shared paper, 2025 · strength 0.16
  25. Lisa M. Coussens · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.